BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12881117)

  • 1. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone.
    al-Helw AA; Al-Angary AA; Mahrous GM; al-Dardari MM
    J Microencapsul; 1998; 15(3):373-82. PubMed ID: 9608399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.
    Thanoo BC; Sunny MC; Jayakrishnan A
    J Pharm Pharmacol; 1992 Apr; 44(4):283-6. PubMed ID: 1355537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.
    Gupta KC; Jabrail FH
    Carbohydr Res; 2006 May; 341(6):744-56. PubMed ID: 16499893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
    Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
    AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
    Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
    J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual cross-linked chitosan microspheres formulated with spray-drying technique for the sustained release of levofloxacin.
    Zhou J; Chen Y; Luo M; Deng F; Lin S; Wu W; Li G; Nan K
    Drug Dev Ind Pharm; 2019 Apr; 45(4):568-576. PubMed ID: 30652515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent.
    Kumbar SG; Kulkarni AR; Aminabhavi M
    J Microencapsul; 2002; 19(2):173-80. PubMed ID: 11837972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long acting biodegradable controlled delivery of chitosan microspheres loaded with tetanus toxoide as model antigen.
    Varma S; Sadasivan C
    Biomed Pharmacother; 2014 Mar; 68(2):225-30. PubMed ID: 24051124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of betamethasone-loaded chitosan microparticles by spray-drying method.
    Huang YC; Yeh MK; Cheng SN; Chiang CH
    J Microencapsul; 2003; 20(4):459-72. PubMed ID: 12851046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorouracil loaded chitosan microspheres for chemoembolization.
    Denkbaş EB; Seyyal M; Pişkin E
    J Microencapsul; 1999; 16(6):741-9. PubMed ID: 10575626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman.
    Gupta KC; Jabrail FH
    Carbohydr Res; 2007 Nov; 342(15):2244-52. PubMed ID: 17610856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and in vitro characterization of spray dried microspheres of amoxicillin.
    Raval JA; Patel JK; Patel MM
    Acta Pharm; 2010 Dec; 60(4):455-65. PubMed ID: 21169137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical cross-linking: A feasible approach to prolong doxylamine/pyridoxine release from spray-dried chitosan microspheres.
    Katsarov P; Pilicheva B; Uzunova Y; Gergov G; Kassarova M
    Eur J Pharm Sci; 2018 Oct; 123():387-394. PubMed ID: 30077710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin.
    Bayomi MA
    Drug Dev Ind Pharm; 2004 Apr; 30(4):329-39. PubMed ID: 15132175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of novel semi-interpenetrating polymer network hydrogel microspheres of chitosan and hydroxypropyl cellulose for controlled release of chlorothiazide.
    Rokhade AP; Kulkarni PV; Mallikarjuna NN; Aminabhavi TM
    J Microencapsul; 2009 Feb; 26(1):27-36. PubMed ID: 18608812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.
    Du YZ; Ying XY; Wang L; Zhai Y; Yuan H; Yu RS; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):164-9. PubMed ID: 20362652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.